openPR Logo
Press release

Fertility Nutraceuticals, LLC Launches FERTINATAL Micronized DHEA Supplement for Enhanced Female Fertility

12-23-2011 04:11 AM CET | Health & Medicine

Press release from: Fertility Nutraceuticals, LLC

Fertility Nutraceuticals, LLC Launches FERTINATAL Micronized

Fertility Nutraceuticals, LLC – a company specializing in nutritional supplements for women and female fertility enhancement – is announcing the launch of FERTINATAL™ micronized dehydroepiandrosterone (DHEA) supplement. The high-quality DHEA supplement is designed to augment female fertility.

Intrigued by anecdotal evidence received from one of their patients, physicians at New York’s Center for Human Reproduction (CHR) – a leading fertility and research center – initiated research on the relationship between DHEA supplementation and enhanced female fertility. Although research on the effects of DHEA is still limited, the published results of CHR’s studies are encouraging.

FERTINATAL™ was developed to offer the public exactly the same kind of DHEA utilized by CHR in the center’s research studies. The product features the highest quality control standards, including a triple-step testing process with batch-testing by independent laboratories. Furthermore, FERTINATAL™ is micronized to the same particle sizes as used in those studies. The product’s three-step testing process ensures that FERTINATAL™ delivers on its three promises: a plant-derived DHEA product of highest quality, micronized to appropriate sizes for good absorption.

FERTINATAL™ is the first DHEA supplement exclusively designed for women and female fertility enhancement. To improve convenience, it is uniquely packaged in individual blister sheets, each containing seven (7) rows of three (3) daily tablets, representing one week of the suggested supply of DHEA supplementation. Each box of FERTINATAL™ contains four of these blister sheets (a four-week supply). FERTINATAL™ is not intended for individuals under the age of 18, and potential side effects are described on the product’s packaging.

FERTINATAL™ will become available exclusively through Fertility Nutraceuticals, LLC in January 2012.

About Fertility Nutraceuticals, LLC
Fertility Nutraceuticals, LLC is a newly established company exclusively dedicated to nutritional supplements for women and enhanced female fertility. FERTINATAL™ DHEA supplement is the company’s first product, with as many as 2-3 additional products expected to arrive throughout 2012. For more information, visit http://www.fertinatal.com.

Director of Marketing and Sales
Fertility Nutraceuticals, LLC
1015 Madison Avenue #504
New York, NY 10075
212-628-0851

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fertility Nutraceuticals, LLC Launches FERTINATAL Micronized DHEA Supplement for Enhanced Female Fertility here

News-ID: 205132 • Views:

More Releases from Fertility Nutraceuticals, LLC

FERTINATAL™ DHEA Supplement for Diminished Ovarian Reserve Hits the Market
FERTINATAL™ DHEA Supplement for Diminished Ovarian Reserve Hits the Market
(New York, NY) – FERTINATAL™, the first and only dehydroepiandrosterone (DHEA) nutritional supplement designed to enhance female fertility, has entered the market today. The launch took longer than expected, because Fertility Nutraceuticals, LLC - which developed the supplement - made unusual efforts to ensure that FERTINATAL™ DHEA for women would fulfill all of the required specifications which the product was designed for, with consistency across every tablet, according to Fertility Nutraceuticals.

More Releases for FERTINATAL™

Open Therapeutics and doDOC™ Partner to Integrate doDOC™ Content Management …
Open Therapeutics and doDOC™ Partner to Integrate doDOC™ Content Management System into Therapoid™. Innovative manuscript development tool to be integrated into scientific collaboration platform. Minneapolis, MN and Boston, MA – June 27, 2018 – Open Therapeutics LLC, a scientific collaboration platform company, and doDOC, a online collaborative writing tool that allows researchers to plan, draft, edit, review and approve professional documents more than 70% faster, have partnered. Therapoid™ will freely
MetaFix™ PlantarMAX™ Foot Plate received FDA-Release
Merete Medical GmbH announces the FDA-approval for MetaFix™ PlantarMAX™ plate. PlantarMAX™ is designed as the first plantar/medial Lapidus fixation plate which takes advantage of the biomechanically superior fixation on the tension side of the Metatarsal/Cuneiform joint during a Lapidus Hallux Valgus correction procedure. The fixation on the tension side of the joint is superior to dorsal or medial fixation and offers additional compression as the patient proceeds to weight bearing. Merete
Dali Wireless™ Introduces its Low Power t-Series Solution: tHost™ and t30™
Palo Alto, October 25, 2012 – Dali Wireless, a leader in next generation wireless infrastructure, today announced the release of its low power t-Series solution, which consists of the t30 remote unit and the tHost head-end. The exponential growth of mobile data capacity is challenging traditional cellular networks. Dali Wireless has created a unique solution to address these capacity limitations by combining industry standard protocols with the culmination of over
FERTINATAL™ DHEA Supplement for Diminished Ovarian Reserve Hits the Market
(New York, NY) – FERTINATAL™, the first and only dehydroepiandrosterone (DHEA) nutritional supplement designed to enhance female fertility, has entered the market today. The launch took longer than expected, because Fertility Nutraceuticals, LLC - which developed the supplement - made unusual efforts to ensure that FERTINATAL™ DHEA for women would fulfill all of the required specifications which the product was designed for, with consistency across every tablet, according to Fertility Nutraceuticals.
GFI™ Software Announces GFI LANguard™ 2011
Clearwater, FL – May 23, 2011 – GFI Software’s Infrastructure Business Unit today announced the launch of GFI LANguard™2011, the latest version of the company’s comprehensive network vulnerability scanning and patch management solution. GFI LANguard 2011 is the first network vulnerability and patch management solution to integrate with more than 1,500 security applications and to include keyword search functionality, illustrating GFI’s commitment to providing small and medium-sized businesses (SMBs) with
SaferWatch™ announces TIN Manager™
HEBRON, ND – SaferWatch announces the release of their latest software solution, TIN Manager™. The TIN Manager feature is designed to verify the accuracy of Taxpayer Identification Number (TIN) and name information prior to submitting 1099’s to the IRS so that the company will not be penalized or fined for mismatches. TIN Manager eliminates tax preparation hassles by giving the bookkeeping departments of broker and shipper businesses a